Status:
RECRUITING
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Lead Sponsor:
Northern Jiangsu People's Hospital
Conditions:
Cirrhoses, Liver
Splenectomy; Status
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical ...
Detailed Description
Patients meeting the study's inclusion criteria were enrolled, and their baseline demographic data were collected. Eligible patients were randomly assigned in a 1:1 ratio to two groups: the laparoscop...
Eligibility Criteria
Inclusion
- A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
- Splenomegaly with secondary hypersplenism
- gastroesophageal variceal bleeding
- Informed consent to participate in the study
Exclusion
- Hepatocellular carcinoma or any other malignancy,
- Child-Pugh grade C
- Recent peptic ulcer disease
- History of Hemorrhagic stroke
- Pregnancy.
- Uncontrolled Hypertension
- Human immunodeficiency virus (HIV) infection
Key Trial Info
Start Date :
September 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 24 2028
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07205471
Start Date
September 24 2025
End Date
September 24 2028
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Medical College of Yangzhou University
Yangzhou, Jiangsu, China, 225001